Journal Logo

Errata

The Potential Role of Efficacy and Safety Evaluation of N-Acetylcysteine Administration During Liver Procurement. The NAC-400 Single Center Randomized Controlled Trial: Erratum

doi: 10.1097/TP.0000000000004154
  • Free

In the article “The Potential Role of Efficacy and Safety Evaluation of N-Acetylcysteine Administration During Liver Procurement. The NAC-400 Single Center Randomized Controlled Trial” by Gómez-Gavara et al, which published in the October 2021 issue of Transplantation, the sixth author’s affiliation appears incorrectly. The correct affiliation for Rafael López-Andújar is CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.

REFERENCE

Gómez-Gavara C, Moya-Herraiz Á, Hervás D, et al. The potential role of efficacy and safety evaluation of N-acetylcysteine administration during liver procurement. The NAC-400 Single center randomized controlled trial. Transplantation. 2021;105:2245–2254.
    Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.